Rex H. Lee
Impact in
-
- Head and Neck Cancer Studies
-
- COVID-19 and healthcare impacts
- Ear and Head Tumors
- Cancer-related Molecular Pathways
Papers in
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 1
- COVID-19 and healthcare impacts 1
- Ear and Head Tumors 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Hyunseok Kang (4 shared papers)Katherine C. Wai (5 shared papers)Patrick K. Ha (6 shared papers)Daniel E. Johnson (2 shared papers)Sue S. Yom (1 shared paper)Jennifer R. Grandis (2 shared papers)Agata Smogorzewska (1 shared paper)Jonathan R. George (5 shared papers)
- Journals
- Cancers (2 papers)Otolaryngology (2 papers)Head & Neck (2 papers)PLoS ONE (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesIsrael
In The Last Decade
Rex H. Lee
10 papers receiving 114 citations
Peers
Comparison fields: 5 of 38
- Otorhinolaryngology 16
- Oncology 45
- Periodontics 4
- Surgery 26
- Internal Medicine 2
Countries citing papers authored by Rex H. Lee
This map shows the geographic impact of Rex H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rex H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rex H. Lee more than expected).
Fields of papers citing papers by Rex H. Lee
This network shows the impact of papers produced by Rex H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rex H. Lee. The network helps show where Rex H. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Rex H. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 27 | |
| 2 | 2021 | 23 | |
| 3 | 2019 | 16 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 13 | |
| 6 | 2023 | 7 | |
| 7 | 2021 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 2 |
About Rex H. Lee
Rex H. Lee is a scholar working on Oncology, Molecular Biology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 10 papers that have together received 114 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (3 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Angiogenesis and VEGF in Cancer (1 paper), COVID-19 and healthcare impacts (1 paper), Oral health in cancer treatment (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Brain Metastases and Treatment (1 paper) and Ear and Head Tumors (1 paper). The work is most often cited by research in Otorhinolaryngology (16 citations), Oncology (45 citations), Periodontics (4 citations), Surgery (26 citations) and Internal Medicine (2 citations). Rex H. Lee has collaborated with scholars based in United States and Israel. Frequent co-authors include Hyunseok Kang, Katherine C. Wai, Patrick K. Ha, Daniel E. Johnson, Sue S. Yom, Jennifer R. Grandis, Agata Smogorzewska, Jonathan R. George, Kunakorn Atchaneeyasakul and Chase M. Heaton. Their work appears in journals such as Cancers, Otolaryngology, Head & Neck, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.